Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05381740 · ClinicalTrials.gov registry record · Early Phase 1
A Novel Brain Stimulation for Bimanual Motor Function and Control in Chronic Stroke
A Early Phase 1 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 17
- Enrollment target
NCT05381740 is a Early Phase 1 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 17 participants.
The verdict
NCT05381740, a Early Phase 1 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The long-term goal of this project is to develop and test upper Iimb rehabilitation interventions that can improve bimanual motor function, or the ability to use both arms and hands together, for stroke survivors with moderate to severe impairment. This study will utilize a novel method of non-invasive brain stimulation in conjunction with upper limb training given for 12 visits over a period of 6 weeks. The study will include the following site visits: * Eligibility Screening and Informed Consent Visit * Baseline testing (4 visits total): 1 visit each for MRI, upper limb and bimanual motor function test, bimanual motor control, and neurophysiology related to control of the upper limbs * Repeat baseline testing (4 visits total) of MRI, upper limb and bimanual motor function test, bimanual motor control, and neurophysiology related to control of the upper limbs * 12 intervention visits during which patients will receive upper limb therapy in conjunction with non-invasive brain stimulation * Repeat testing (4 visits total) of MRI, upper limb and bimanual motor function test, bimanual motor control, and neurophysiology related to control of the upper limbs * A follow-up visit 1 month after the completion of interventions
Interventions
- DEVICE Novel rTMS Approach
- DEVICE Sham rTMS Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-03-08 |
| Est. Completion | 2024-01-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05381740
The ClinicalTrials.gov registry entry for NCT05381740 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Novel rTMS Approach is the first listed.
NCT05381740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05381740 about?
NCT05381740 is a clinical study titled "A Novel Brain Stimulation for Bimanual Motor Function and Control in Chronic Stroke". The long-term goal of this project is to develop and test upper Iimb rehabilitation interventions that can improve bimanual motor function, or the ability to use both arms and hands together, for stroke survivors with moderate to severe impairment. This study will utilize a novel method of non-inva...
What is the current status of trial NCT05381740?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 17 participants. The study started on 2022-03-08. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT05381740?
The interventions under investigation include: Novel rTMS Approach (DEVICE), Sham rTMS Approach (DEVICE).
Who is sponsoring clinical trial NCT05381740?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.